Daniela Lehnen

Title: Daniela Lehnen: Innovator in Cell Composition Technology

Introduction

Daniela Lehnen is a prominent inventor based in Cologne, Germany. She has made significant contributions to the field of biotechnology, particularly in the generation of cell compositions for medical applications. Her innovative work has the potential to advance treatments for various neurological conditions.

Latest Patents

Daniela Lehnen holds a patent for a method for the generation of a cell composition of mesencephalic dopaminergic progenitor cells. This invention provides a systematic approach to differentiate pluripotent and/or multipotent stem cells into mesencephalic dopaminergic progenitor cells. The method involves several steps, including the dissociation of differentiated cells into a single-cell suspension and the enrichment of progenitor cells using an antigen binding molecule specific for the CD47 antigen. This process can be performed in a closed cell sample processing system and may be automated, enhancing efficiency in cell therapy applications. She has 1 patent to her name.

Career Highlights

Daniela is currently associated with Miltenyi Biotec GmbH, a leading company in the field of biotechnology. Her role involves research and development focused on innovative solutions for cell therapy and regenerative medicine. Her expertise and dedication have positioned her as a key player in her field.

Collaborations

Daniela has collaborated with notable colleagues, including Andreas Bosio and Sebastian Knobel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Daniela Lehnen's contributions to biotechnology, particularly in the generation of cell compositions, highlight her role as an influential inventor. Her work not only advances scientific knowledge but also holds promise for future medical applications.